Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methadone, a full mu-opioid agonist, is the recommended treatment for opioid dependence during pregnancy. However, prenatal exposure to methadone is associated with a neonatal abstinence syndrome (NAS) characterized by central nervous system hyperirritability and autonomic nervous system dysfunction, which often requires medication and extended hospitalization. Buprenorphine, a partial mu-opioid agonist, is an alternative treatment for opioid dependence but has not been extensively studied in pregnancy. METHODS: We conducted a double-blind, double-dummy, flexible-dosing, randomized, controlled study in which buprenorphine and methadone were compared for use in the comprehensive care of 175 pregnant women with opioid dependency at eight international sites. Primary outcomes were the number of neonates requiring treatment for NAS, the peak NAS score, the total amount of morphine needed to treat NAS, the length of the hospital stay for neonates, and neonatal head circumference. RESULTS: Treatment was discontinued by 16 of the 89 women in the methadone group (18%) and 28 of the 86 women in the buprenorphine group (33%). A comparison of the 131 neonates whose mothers were followed to the end of pregnancy according to treatment group (with 58 exposed to buprenorphine and 73 exposed to methadone) showed that the former group required significantly less morphine (mean dose, 1.1 mg vs. 10.4 mg; P<0.0091), had a significantly shorter hospital stay (10.0 days vs. 17.5 days, P<0.0091), and had a significantly shorter duration of treatment for the neonatal abstinence syndrome (4.1 days vs. 9.9 days, P<0.003125) (P values calculated in accordance with prespecified thresholds for significance). There were no significant differences between groups in other primary or secondary outcomes or in the rates of maternal or neonatal adverse events. CONCLUSIONS: These results are consistent with the use of buprenorphine as an acceptable treatment for opioid dependence in pregnant women. (Funded by the National Institute on Drug Abuse; ClinicalTrials.gov number, NCT00271219.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the length, but not intensity, of neonatal abstinence syndrome and the neonates’ need for morphine relief was lower in women taking buprenorphine compared to methadone”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
The cited source says what the claim attributes to it.
In the citing paper
“there was lower retention in the buprenorphine treated group.”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782 · cited 3×
“Eye, ear, nose, or throat problems 12 (14) 15 (17) 1 (1) 1 (2)”
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366 · cited 4×
“Obstetrical problems 29 (33) 23 (27) 3 (4) 4 (7)”
InfluentialBuprenorphine suppresses heroin use by heroin addicts
Mello, N. K., & Mendelson, J. H. (1980) · Science · doi:10.1126/science.7352279 · Cited by 298
Jones, H. E., Johnson, R. E., Jasinski, D. R., O’Grady, K. E., Chisholm, C. A., Choo, R. E., Crocetti, M., Dudas, R., Harrow, C., Huestis, M. A., et al. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.11.013 · Cited by 295
Self-citationOPIOID DEPENDENCE DURING PREGNANCY
Kaltenbach, K., Berghella, V., & Finnegan, L. (1998) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70362-4 · Cited by 287
Self-citation
Research works printed but not linked: 4
- 10.1111/j.1360-0443.1997.tb02877.x · doi:10.1111/j.1360-0443.1997.tb02877.x · Paper page
- Mattick RP, 2009, Cochrane Database Syst Rev, 3, CD002209
- Finnegan LP, Kaltenbach K. Neonatal abstinence syndrome. In Hoekelman RA, Friedman SB, Nelson NM, et al., eds. Primary pediatric care. 2nd ed. St. Louis: Mosby, 1992:1367-78.
- Mattick RP, 2008, Cochrane Database Syst Rev, 2, CD002207
Cited by
Items 701–800 of 1,000
Pharmacist led vaccination rates in opioid addicted obstetric patients
Forinash, A. B., Yancey, A. M., & Shyken, J. M. (2020) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1364 · Cited by 3
Clearance of buprenorphine during pregnancy and neonatal outcomes
Coker, J. L., Ray-Griffith, S. L., McLeod, C., Han, X., Mancino, M. J., Kearns, G. L., & Stowe, Z. N. (2021) · Archives of Women s Mental Health · doi:10.1007/s00737-021-01128-1 · Cited by 3
Thomson, S., Khalil, A. M., Hafford, S., & Waterstone, M. (2021) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12779 · Cited by 3
Comparison of Two Morphine Dosing Strategies in the Management of Neonatal Abstinence Syndrome
Harris, J. B., & Holmes, A. P. (2022) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-27.2.151 · Cited by 3
Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan
Goshgarian, G., Jawad, R., O'Brien, L., Muterspaugh, R., Zikos, D., Ezhuthachan, S., Newman, C., Hsu, C., Bailey, B. A., & Ragina, N. P. (2022) · Cureus · doi:10.7759/cureus.27790 · Cited by 3
Heil, S. H., Melbostad, H. S., & Cioffredi, L. (2023) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780197618431.013.9 · Cited by 3
Self-citationPregnancy and Postpartum-Related Pain
Fitzgerald, C. M. (2012) · Springer eBooks · doi:10.1007/978-1-4419-7113-5_9 · Cited by 3
Managing Patients with Chronic Pain and Opioid Addiction
Taylor, D. R. (2015) · Springer eBooks · doi:10.1007/978-3-319-08111-3 · Cited by 3
Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Papile, L. A. (2011) · Yearbook of Neonatal and Perinatal Medicine · doi:10.1016/j.ynpm.2011.07.061 · Cited by 3
Lauzon, P. (2012) · Drogues santé et société · doi:10.7202/1007848ar · Cited by 3
Rubio, M. M. (2013) · UWM Digital Commons (University of Wisconsin–Milwaukee) · Cited by 3
Controlled Substance Management: Exit Strategies for the Pain Practitioner
Silverman, S. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-30964-4_14 · Cited by 3
Wood, T. E., Bordelon, C., & Fogger, S. A. (2019) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000267 · Cited by 3
Spada, M. L., Kmiec, J. A., Glance, J. B., & Gopalan, P. K. (2020) · Substance Abuse · doi:10.1080/08897077.2019.1635970 · Cited by 3
Update on the Neuropsychiatry of Substance Use Disorders
Kolodner, G., & Koliatsos, V. E. (2020) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2020.02.011 · Cited by 3
Adverse neonatal outcomes associated with maternal severe mental health diagnoses and opioid use
Ma, J., Sahasranaman, V., Kirby, R. S., & Boaz, T. L. (2020) · Journal of Perinatology · doi:10.1038/s41372-020-0759-1 · Cited by 3
Ocular disorders in children exposed in utero to buprenorphine
O’Connor, A. B., O’Brien, L. M., Rifai, T., Ballem, G., Housman, S. L., Devore, N., & Schumacher-Feero, L. A. (2021) · Journal of Substance Use · doi:10.1080/14659891.2021.1879293 · Cited by 3
Non-pharmacological care for opioid withdrawal in newborns
Pahl, A., Young, L., Buus‐Frank, M. E., Marcellus, L., & Soll, R. F. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013217 · Cited by 3
Resource utilization and convalescent care cost in neonatal opioid withdrawal syndrome
Ronan, K., Driscoll, C. A. H., Decker, E., Gopalakrishnan, M., & El‐Metwally, D. (2022) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-221060 · Cited by 3
Soyka, M., & Hillemacher, T. (2013) · Addiction · doi:10.1111/add.12376 · Cited by 3
Comment on ‘The Complex Factors Determining Neonatal Abstinence Syndrome and Its Management’
Baewert, A., & Unger, A. (2012) · European Addiction Research · doi:10.1159/000342488 · Cited by 3
PREGNANT WOMEN IN OPIOID MAINTENANCE TREATMENT (OMT): MATERNAL AND NEONATAL OUTCOMES
Lund, I. O. (2013) · NORA - Norwegian Open Research Archives · Cited by 4
Prevention, Recognition, and Treatment of Opioid Use Disorder in Obstetrics: A Call to Action
McCance‐Katz, E. F., & Adams, J. M. (2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003310 · Cited by 3
Duran, J., Khalid, S., Richardson, L., Bosse, K. E., & Brummelte, S. (2025) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_570 · Cited by 2
Wilson, L. A., Kurz, M., Guerra‐Alejos, B. C., Min, J. E., Ti, L., & Nosyk, B. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-095461 · Cited by 2
Varney, B., Jones, N. R., Bharat, C., Brett, J., Degenhardt, L. J., Oei, J. L., Pearson, S., Havard, A., & Tran, D. T. (2026) · Addiction · doi:10.1111/add.70325 · Cited by 2
Friedrich, S., Huybrechts, K. F., Straub, L., Hernández–Díaz, S., Zhu, Y., Hahn, G., Mogun, H., Jones, H. E., Connery, H. S., Davis, J. M., et al. (2026) · BMJ · doi:10.1136/bmj-2025-087321 · Cited by 2
Self-citationWilson, L. A., Tobias, S., Gandhi, P., Nosyk, B., Buxton, J. A., & Ti, L. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-09256-1 · Cited by 2
Neonatal abstinence syndrome: a never ending story!
van den Anker, J. N. (2013) · Journal of pediatric and neonatal individualized medicine · doi:10.7363/020231 · Cited by 2
Prise en charge du nouveau-né de mère dépendante aux opiacés
Mazurier, E., Chanal, C., Misraoui, M., Toubin, R.-M., Boulot, P., & Cambonie, G. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0385-2_23 · Cited by 2
Bell, M. F., Kelty, E. A., Segal, L., Dennison, S. M., Kinner, S. A., Dawe, S., Spittal, M. J., & Preen, D. B. (2023) · Australian Journal of Social Issues · doi:10.1002/ajs4.296 · Cited by 2
A Review of Neonatal Selective Serotonin Reuptake Inhibitor Withdrawal Syndrome
Mamillapalli, L., Lu, S., Witkin, J., Gavaskar, R., Cheng, A., McIntyre, K., Aboujaoude, E. R., Gonzalez, J., Siu, A., & Sturgill, M. G. (2025) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/jppt-24-00010 · Cited by 2
Case Presentations from the Addiction Academy
Laes, J. R., & Wiegand, T. J. (2015) · Journal of Medical Toxicology · doi:10.1007/s13181-015-0520-x · Cited by 2
Opioid Use Disorder in Pregnancy
Sanjanwala, A. R., & Harper, L. M. (2019) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000419 · Cited by 2
Neonatal Opioid Withdrawal Syndrome
Easterlin, M. C., Ramanathan, R., & Beritto, T. V. D. (2022) · Pediatric Annals · doi:10.3928/19382359-20220407-05 · Cited by 2
Do small for gestational age infants have less severe neonatal abstinence syndrome?
Friedman, D., Zubair, N., Favara, M. T., Lafferty, M. A., Carola, D. L., Adeniyi-Jones, S. C., Solarin, K. O., & Aghai, Z. H. (2022) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-221053 · Cited by 2
Cortez, J. M., & Hudak, M. L. (2023) · Current Treatment Options in Pediatrics · doi:10.1007/s40746-023-00281-2 · Cited by 2
Developmental outcomes with perinatal exposure (DOPE) to prescription opioids
Flores, A., Nguyen, N. M., & Pendyala, G. (2023) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2023-0017 · Cited by 2
Poland, C. A., Shadur, J. M., Cinader, M. K., & Felton, J. W. (2023) · Psychiatric Research and Clinical Practice · doi:10.1176/appi.prcp.20230033 · Cited by 2
Getsy, P. M., Coffee, G. A., Bates, J. N., Parran, T. V., Hoffer, L., Baby, S. M., MacFarlane, P. M., Knauss, Z. T., Damron, D. S., Hsieh, Y., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1444574 · Cited by 2
A Pharmacologic Evaluation of Buprenorphine in Pregnancy and the Postpartum Period
Caritis, S. N., & Venkataramanan, R. (2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001380 · Cited by 2
Current Perspectives on Substance Use Disorders in Afghanistan
Shaikh, O. A., Shoib, S., Saeed, F., & Nazari, S. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-6619-2_2 · Cited by 2
Pharmacists' contributions to the management of opioid use disorder
Stranges, P. M., Adams, K. K., Alharir, A., Burnam, L. G., Elmes, A. T., Greenlee, S. B., Infante, A. F., Kerins, A., Ma, Q., Meyenburg, L. K., et al. (2025) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.70049 · Cited by 2
Perinatal Addictions: Intrauterine Exposures
Vélez, M. L., & Jansson, L. M. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_100 · Cited by 2
Sivashanker, K., Mufson, M. J., Mittal, L. P., Ross, E. L., & Suzuki, J. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000080 · Cited by 2
Greenfield, S. F., & Weiss, R. D. (2017) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000159 · Cited by 2
Dual dilemma—should naltrexone be used in the treatment of opioid‐dependent pregnant women?
Stitzer, M. L. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.03883.x · Cited by 2
Buprenorphine in TheTreatment of Heroin Addiction /
Bell, J. R. (2012) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn20122502001 · Cited by 2
Liell, C. C., & Bayer, A. (2016) · Revista Eletrônica de Educação Matemática · doi:10.5007/1981-1322.2015v10n2p124 · Cited by 2
Kramlich, D. L., Kronk, R. A., & Jakub, K. (2017) · The Qualitative Report · doi:10.46743/2160-3715/2017.2644 · Cited by 2
Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum
Akinlaja, O. A., & Gist, W. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.035 · Cited by 2
Wallen, L. D., & Gleason, C. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40139-5.00013-9 · Cited by 2
Supporting breastfeeding for infants born to opioid dependent mothers June 18, 2018
Groer, M. E., Maguire, D. J., & Taylor, K. (2018) · Nursing Outlook · doi:10.1016/j.outlook.2018.07.003 · Cited by 2
Treatment of Substance Use Disorders
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.003.0005 · Cited by 2
Stephens, S., & Yates, L. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408078-2.00022-6 · Cited by 2
Opioids and Opiates: Pharmacology, Abuse, and Addiction
Cruz, S. L., & Granados‐Soto, V. (2022) · Springer eBooks · doi:10.1007/978-3-030-88832-9_156 · Cited by 2
Chapter 63. Psychopharmacology During Pregnancy and Lactation
Newport, D. J., di Scalea, T. L., Richardson, E., Smith, T. L., Scott, N. P., & Stowe, Z. N. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as63 · Cited by 2
Maternal and Neonatal Morbidity: Dual Harms Associated with Addiction in Pregnancy
Gordon, A. J. (2014) · Substance Abuse · doi:10.1080/08897077.2014.869442 · Cited by 2
Health of prenatally buprenorphine-exposed children to three years of age
Kivistö, K. (2015) · Helda - University of Helsinki Institutional Repository · Cited by 2
Whitham, J. N. (2012) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 2
Snyder, A. M., Math, S., Campbell, K. A., Schiff, D. M., Wheeler, A., Carlston, K., Gordon, A. J., Winhusen, T. M., Cochran, G., & Smid, M. C. (2025) · Substance Use & Addiction Journal · doi:10.1177/29767342251334490 · Cited by 2
Methadone and Buprenorphine Use During the Perinatal Period
Ordean, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6974-2_16 · Cited by 1
Prenatal Drug Use: Neonatal Effects and the Neonatal Withdrawal Syndrome
Ostrea, E. M., Cortez, J. M., Alviedo, N. J. B., Bañadera, F. D. P., Jesus, L. C. D., & Cheng, C. T. (2020) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610022255-29 · Cited by 1
Alcohol and Drug Use Disorders
Baca-Atlas, M., Baca-Atlas, S. N., & Fedoriw, K. B. (2023) · Springer eBooks · doi:10.1007/978-3-031-29171-5_6 · Cited by 1
Smith, D., Sullivan, R. E., Allen, E. C., Pradhan, S., Zhu, J., & Oji‐Mmuo, C. N. (2024) · Clinical Pediatrics · doi:10.1177/00099228241246647 · Cited by 1
Nnanna, T. B. (2024) · International Journal of Pharmacy and Chemistry · doi:10.11648/j.ijpc.20241004.11 · Cited by 1
Buprenorphine: New Challenges and Opportunities
da Costa, S. C., Ghafouri, M., Jorandby, L., Rummans, T. A., & Gold, M. S. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00626-x · Cited by 1
Townsel, C., Biroon, F. A., Broni, E. K., Turner, M. D., Govindan, V., Sabet, S., Tarui, A., Willimas, S. A. S., Goodrich, J. M., Dolinoy, D. C., et al. (2025) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2025.101866 · Cited by 1
Animal Models of Prenatal Opioid Exposure: Insights into Impaired Neurodevelopment
Valery, C. B., Madurai, N. K., & Jantzie, L. L. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12741-9_11 · Cited by 1
Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome
Painter, A. E., Westphal, K., Herrera, A., Lewis, E., Sweeney, A., & Sutton, A. G. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12741-9_12 · Cited by 1
Zbylut, K., Herman, A. M., Herman, M. P., Gurule, F. S., Goldstein, J. T., & Leeman, L. (2026) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.70173 · Cited by 1
Simard‐Duplain, G., & Zhang, J. (2026) · PNAS Nexus · doi:10.1093/pnasnexus/pgag024 · Cited by 2
Jones, H. E., & Heil, S. H. (2026) · Preventive Medicine · doi:10.1016/j.ypmed.2026.108643 · Cited by 1
Self-citationThe quality of outreach workers and the services they provide for the NSEP program in Malaysia
Baba, I., & Azman, A. (2014) · Universiti Utara Malaysia Institutional Repository (Universiti Utara Malaysia) · Cited by 1
Jones, H. E., Kaltenbach, K. A., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O’Grady, K. E., Selby, P. L., & Martin, P. (2012) · American Journal on Addictions · doi:10.1111/j.1521-0391.2012.00289.x · Cited by 1
Self-citationLaser acupuncture for neonatal abstinence syndrome: a randomized controlled trial
Buschmann-Prayon, K., Raith, W., Schmölzer, G. M., Resch, B., Reiterer, F., Avian, A., Köestenberger, M., & Urlesberger, B. (2016) · Deutsche Zeitschrift für Akupunktur · doi:10.1016/s0415-6412(16)30047-9 · Cited by 1
Habal, R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05472-0.00178-x · Cited by 1
Davis, G. H. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.007 · Cited by 1
Morphine vs methadone in the treatment of neonatal abstinence syndrome
Cooney, H., Hodgson, K. A., & Davis, P. G. (2019) · Acta Paediatrica · doi:10.1111/apa.14846 · Cited by 1
(2014) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000031 · Cited by 1
Writers, A. M. (2016) · Drugs & Therapy Perspectives · doi:10.1007/s40267-016-0281-x · Cited by 1
Brandt, L., Swoboda, P., Fischer, G., & Unger, A. (2016) · Substance Abuse · doi:10.1080/08897077.2016.1184738 · Cited by 1
Self-citationPregnant women with substance use disorders: The intersection of history, ethics, and advocacy
Acquavita, S. P., Kauffman, S. S., Talks, A., & Sherman, K. (2016) · Social Work in Health Care · doi:10.1080/00981389.2016.1232670 · Cited by 1
Mise à jour sur l’utilisation clinique de la buprénorphine
Ducharme, S., Fraser, R., & Gill, K. (2012) · Canadian Family Physician · Cited by 2
Ferrell, G. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.014 · Cited by 1
Substance Use in Women and Pregnancy
Roche, N., & Oparaji, D. C. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.050 · Cited by 1
Cardiovascular Disease in Pregnancy
Graves, C. R. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.037 · Cited by 1
Gastrointestinal Disorders in Pregnancy
Patrick, S. K., & Schneider, K. M. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.042 · Cited by 1
Selected Endocrine Disorders in Pregnancy
Chen, K. K. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.043 · Cited by 1
Davis, G. H. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.054 · Cited by 1
Neonatal abstinence syndrome and medical social service management
Bülbül, A., Celiker, E. Y., Calapcikay, U., & Uslu, S. (2017) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.5350/semb.20170911063035 · Cited by 1
Drogenabusus in der Schwangerschaft – Risiko für das Kind
Robel‐Tillig, E. (2017) · Frauenheilkunde up2date · doi:10.1055/s-0043-123868 · Cited by 1
An Infant with Neonatal Abstinence Syndrome in the Setting of Hydranencephaly
Avidan, O., Craig, A. K., & Deerwester, K. (2017) · Journal of Pediatric Neurology · doi:10.1055/s-0037-1608948 · Cited by 1
Diagnostik und Therapie bei Kindern drogenabhängiger Mütter
Mücke, S. (2017) · doi:10.1007/978-3-89935-307-5_6 · Cited by 1
Benson, J. G., MacLean, P. C., Hsi, A., & Erickson, S. J. (2017) · UNM’s Digital Repository (University of New Mexico) · Cited by 1
Orsolini, L., Papanti, G. D., Bellantuono, C., Berardis, D. D., & Schifano, F. (2019) · Springer eBooks · doi:10.1007/978-3-319-92919-4_20 · Cited by 1
Schweinhart, A. M., Cargill, V. A., Brady, K. T., Hall, K. L., Spencer, E. A., & Clayton, J. A. (2019) · Journal of Women s Health · doi:10.1089/jwh.2019.29027.pcss · Cited by 1
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.003.0002 · Cited by 1
Psychiatric Illness Co-occurring with a Substance Use Problem
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.003.0008 · Cited by 1
Effects of Substance Use Disorders
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.003.0004 · Cited by 1
Metadata
- Authors
- Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G.
- Affiliations
- Johns Hopkins University (US)
- Thomas Jefferson University (US)
- University of Vermont (US)
- Wayne State University (US)
- Brown University (US)
- University of Maryland, College Park (US)
- University of Toronto (CA)
- Vanderbilt University (US)
- Medical University of Vienna (AT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-12-09
- Volume
- 363
- Issue
- 24
- Pages
- 2320-2331
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3073631
- OpenAlex
- W2025988777
- Cited by
- 986
- References
- 41
- Citations by year
- 2026: 33 · 2025: 38 · 2024: 44 · 2023: 56 · 2022: 45 · 2021: 59 · 2020: 67 · 2019: 97 · 2018: 51 · 2017: 139 · 2016: 72 · 2015: 58 · 2014: 63 · 2013: 56 · 2012: 78
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01 DA15832, R01DA015778, R01DA 017513, R01DA015764, R01DA015832, R01DA015741, R01DA015738, R01DA018410, R01DA018417)
- National Center for Research Resources (M01-RR-109, M01RR000095, M01-RR-00095)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- neonatal abstinence syndrome, methadone, buprenorphine, opioid dependence in pregnancy, prenatal opioid exposure, mu-opioid receptor agonists, neonatal hospital stay, neonatal head circumference
- MeSH terms
- Adult, Buprenorphine, Double-Blind Method, Female, Head, Humans, Infant, Newborn, Length of Stay, Methadone, Morphine, Opioid-Related Disorders, Narcotics, Neonatal Abstinence Syndrome, Pregnancy, Pregnancy Complications, Logistic Models, History, Ancient
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.